Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 09:13 ET | Source: Research and Markets

Active Pharmaceutical Ingredients CDMO Research Report 2025: Global Market Share, Trends, Opportunities, & Forecasts, 2020-2030

Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients CDMO Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" report has been added to ...
December 01, 2025 09:44 ET | Source: Research and Markets

Nucleic Acid Therapeutics CDMO Research Report 2025: An $18.5+ Billion Market by 2030, Driven by Expanding Biopharma R&D, Growing Drug Pipelines, Rising Demand for Specialized Manufacturing

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Nucleic Acid Therapeutics CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
December 01, 2025 09:42 ET | Source: Research and Markets

Nutraceuticals CDMO Forecast Report 2025: A $55+ Billion Market by 2030, Driven by Preventative Healthcare Demand, Aging Populations, and Rising Need for Specialized Formulations

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Nutraceuticals CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
December 01, 2025 09:37 ET | Source: Evestia Clinical

Evestia Clinical Announces New Strategic Advisory Board to Advance Specialist CRO Capabilities Worldwide

New advisory board brings further world-class expertise in oncology, neurology, geographic market expansion, and AI enabled clinical trial delivery to support biotech innovators LETCHWORTH GARDEN...
November 27, 2025 13:42 ET | Source: Dipharma Francis S.r.l

Dipharma publishes a peer-reviewed study in Organic Process Research & Development: a novel approach to detect and characterize nitrosamine formation in APIs

Dipharma publishes a peer-reviewed study introducing a novel 15N NMR–based NAP strategy to detect nitrosamines and strengthen API safety and compliance.
November 21, 2025 07:09 ET | Source: Research and Markets

U.S. Small Molecule CDMO Market Trends Analysis Report 2025-2033: Outsourcing Surge Among Pharma and Biotech Firms Fuels Strong CDMO Growth

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Small Molecule CDMO Market Size, Share & Trends Analysis Report by Drug Type (Generics, Innovators), by Product (APIs, Finished Drug...
November 21, 2025 07:07 ET | Source: Research and Markets

U.S. Cell and Gene Therapy CDMO Market Trends Analysis Report 2025-2033: Gene & CAR-T Therapy Boom Drives Demand for CDMO Partnerships and Specialized Manufacturing Capacity

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy CDMO Market Size, Share & Trends Analysis Report by Phase (Pre-clinical, Clinical), Product (Gene Therapy, Cell Therapy,...
November 18, 2025 12:07 ET | Source: Research and Markets

United States $34.98 Bn Small Molecule CDMO Market Research, Competitive Landscape, Forecasts, Opportunities, 2030 - Pharma Outsourcing Rises and Demand for Specialized Development Capabilities Grows

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "United States Small Molecule CDMO Market, By Region, Competition, Forecast and Opportunities, 2020-2030F" report has been added to ...
November 14, 2025 13:22 ET | Source: EarlyHealth Group

Positioning Barbados as the Caribbean’s Life Sciences Hub

Positioning Barbados as the Caribbean’s Life Sciences Hub: EarlyHealth City to Anchor US$200 Million Investment
November 11, 2025 16:05 ET | Source: Lifecore Biomedical, Inc.

Lifecore Biomedical to Participate in Upcoming Investor Conferences

CHASKA, Minn, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...